減損損失 - 医薬品、減価償却累計額、Reversal Of Reserve For Overseas Investment LossRE他1件
- 【期間】
| 年度 | 減損損失 - 医薬品 | 減価償却累計額 | Reversal Of Reserve For Overseas Investment LossRE | 販売費及び一般管理費（IFRS） |
|---|
| 2008/03 | - | | -0.98兆 | | - | | - | |
| 2009/03 | - | | -1.01兆 | 赤拡 | - | | - | |
| 2010/03 | - | | -1.07兆 | 赤拡 | - | | - | |
| 2011/03 | - | | -1.1兆 | 赤拡 | - | | - | |
| 2012/03 | - | | -1.12兆 | 赤拡 | - | | - | |
| 2013/03 | 4.3億 | | -1.2兆 | 赤拡 | - | | - | |
| 2014/03 | 70.9億 | 大幅増 | -1.29兆 | 赤拡 | - | | - | |
| 2015/03 | 53.1億 | -25.1% | -1.38兆 | 赤拡 | - | | - | |
| 2016/03 | 5.53億 | -89.6% | -1.31兆 | 赤縮 | - | | - | |
| 2017/03 | - | | -1.41兆 | 赤拡 | - | | - | |
| 2018/03 | - | | - | | - | | 5579億 | |
| 2019/03 | - | | - | | - | | 5901億 | +5.8% |
| 2020/03 | - | | - | | - | | 5751億 | -2.5% |
| 2021/03 | - | | - | | - | | 6313億 | +9.8% |
| 2022/03 | - | | - | | - | | 6909億 | +9.4% |
| 2023/03 | - | | - | | - | | 8783億 | +27.1% |
| 2024/03 | - | | - | | - | | 8871億 | +1% |
